Report overview
The global Respiratory Syncytial Virus Diagnostic Testing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Antigen Detection Test Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Respiratory Syncytial Virus Diagnostic Testing include F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc. and Cepheid (Danaher Corporation), etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Respiratory syncytial virus (RSV) is a highly contagious virus that primarily affects the respiratory tract (lungs and breathing passages). It is a common cause of upper and lower respiratory infections in infants, young children, and elderly people. The infection can lead to severe complications such as pneumonia and bronchiolitis.
This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus Diagnostic Testing. This report contains market size and forecasts of Respiratory Syncytial Virus Diagnostic Testing in global, including the following market information:
Global Respiratory Syncytial Virus Diagnostic Testing Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Respiratory Syncytial Virus Diagnostic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Syncytial Virus Diagnostic Testing Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Respiratory Syncytial Virus Diagnostic Testing Market Segment Percentages, by Type, 2023 (%)
Antigen Detection Test
Molecular Diagnostic Test
Direct Fluorescent Antibody Test
Diagnostic Imaging
Others
Global Respiratory Syncytial Virus Diagnostic Testing Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Respiratory Syncytial Virus Diagnostic Testing Market Segment Percentages, by Application, 2023 (%)
Hospitals
Diagnostic Laboratories
Others
Global Respiratory Syncytial Virus Diagnostic Testing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Respiratory Syncytial Virus Diagnostic Testing Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Respiratory Syncytial Virus Diagnostic Testing revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Respiratory Syncytial Virus Diagnostic Testing revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche AG
Abbott
Thermo Fisher Scientific
BD (Becton, Dickinson and Company)
QuidelOrtho Corporation
Hologic, Inc.
Luminex Corporation
Agilent Technologies, Inc.
Cepheid (Danaher Corporation)
DiaSorin S.p.A.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Respiratory Syncytial Virus Diagnostic Testing, market overview.
Chapter 2: Global Respiratory Syncytial Virus Diagnostic Testing market size in revenue.
Chapter 3: Detailed analysis of Respiratory Syncytial Virus Diagnostic Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Respiratory Syncytial Virus Diagnostic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
